肝肾综合征发生的危险因素、诊断和最新分型

李郑红; 董育玮; 陆伦根

doi:10.3969/j.issn.1001-5256.2020.11.003

肝肾综合征发生的危险因素、诊断和最新分型

DOI: 10.3969/j.issn.1001-5256.2020.11.003

上海交通大学附属第一人民医院消化科

详细信息

中图分类号: R575.2;R692
计量
- 文章访问数: 5083
- HTML全文浏览量: 83
- PDF下载量: 240
- 被引次数: 0
出版历程
- 收稿日期: 2020-07-31
- 出版日期: 2020-11-20

Risk factors,diagnosis,and updated classification of hepatorenal syndrome

Department of Gastroenterology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine

摘要

摘要:
肝肾综合征（HRS）是肝硬化失代偿期的常见并发症,传统定义认为进行性少尿或无尿、氮质血症、稀释性低钠血症和低尿钠,而肾脏病理无明显器质性改变的肾功能不全是HRS的典型表现。新近研究发现,除血流动力学异常外,炎症反应、氧化应激及胆汁酸盐的直接肾小管毒性作用共同参与了HRS的发生、发展。HRS并非肝硬化患者的唯一肾脏并发症,其只是急性肾损伤（AKI）的一种功能形式。符合AKI的HRS称之为HRS-AKI,相当于既往的HRS-Ⅰ型。肝硬化患者出现急性肾病（AKD）和慢性肾病（CKD）,如果符合HRS的标准,可诊断为HRS-NAKI,相当于既往的HRS-Ⅱ型。HRS的最常见危险因素是感染,消化道出血和大量放腹水后未输注人血白蛋白扩容。
- 肝肾综合征 /
- 肝硬化 /
- 危险因素 /
- 诊断
Abstract:
Hepatorenal syndrome( HRS) is a common complication of decompensated cirrhosis and is traditionally defined as progressive oliguria or anuria,azotemia,dilutional hyponatremia,and hyponatremia,while renal insufficiency without marked organic lesions in the kidney is the typical manifestation of HRS. Recent studies have found that besides the abnormalities in hemodynamics,inflammatory response,oxidative stress,and direct renal tubular toxicity of bile salts are jointly involved in the development and progression of HRS. HRS is not the only renal complication in patients with liver cirrhosis,and it is only a functional form of acute kidney injury( AKI). HRS meeting the criteria for AKI is called HRS-AKI,which is formerly known as HRS-Ⅰ type. For cirrhotic patients with acute kidney disease or chronic kidney disease,if they meet the criteria for HRS,they can be diagnosed with HRS-NAKI,which is formerly known as HRS-Ⅱ type. The most common risk factors for HRS are infection,digestive bleeding,and large-volume paracentesis without transfusion of human serum albumin for volume expansion.
- hepatorenal syndrome /
- liver cirrhosis /
- risk factors /
- diagnosis

HTML全文

参考文献(24)

[1] LI C,LI WG,XU XY. Clinical advances in hepatorenal syndrome in liver cirrhosis[J]. J Clin Intern Med,2019,36(12):799-802.(in Chinese)李晨，李文刚，徐小元．肝硬化肝肾综合征的临床进展[J]．临床内科病杂志，2019,36(12):799-802.

[2] GINES A,ESCORSELL A,GINES P,et al. Incidence,predictive factors,and prognosis of the hepatorenal syndrome in cirrhosis with ascites[J]. Gastroenterology,1993,105(1):229-236.

[3] WAGN YJ,PING XG. Clinical effect of ascites ultrafiltration and reinfusion in treatment of patients with decompensated cirrhosis,intractable liver ascites,and typeⅡhepatorenal syndrome[J]. Chin J Ctrl Endem Dis,2017,32(10):249-253.(in Chinese)王艳景，平骁功．腹水超滤浓缩回输治疗肝硬化失代偿期合并顽固性肝腹水伴Ⅱ型肝肾综合征的临床效果[J]．中国地方病防治杂志，2017,32(10):249-253.

[4] GINES P,SOLAE,ANGELI P,et al. Hepatorenal syndrome[J]. Nat Rev Dis Primers,2018,4(1):23.

[5] de MATTOSAZ,de MATTOS AA,MENDEZ-SANCHEZ N.Hepatorenal syndrome:Current concepts related to diagnosis and management[J]. Ann Hepatol,2016,15(4):474-481.

[6] PERICLEOUSM,SARNOWSKIA,MOREA,et al. The clinical management of abdominal ascites,spontaneous bacterial peritonitis and hepatorenalsyndrome:A review of curent guidelines and recommendations[J]. Eur J Gastroenterol Hepatol,2016,28(3):e108.

[7] European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J]. J Hepatol,2010,53(3):397-417.

[8] WIEST R,KRAG A,GERBES A. Spontaneous bacterial peritonitis:Recent guidelines and beyond[J]. Gut,2012,61(2):297-310.

[9] EGEROD ISRAELSEN M,GLUUD LL,KRAG A. Acute kidney injury and hepatorenal syndrome in cirrhosis[J]. J Gastroenterol Hepato,2015,30(2):236-243.

[10] LI SY,TIAN YJ,LI DC,et al. Risk factors for hepatorenal syndrome in patients with decompensated cirrhosis[J]. J Chin Physician,2016,18(11):1723-1725.(in Chinese)李思阳，田英俊，李德春，等．肝硬化患者失代偿期发生肝肾综合征的危险因素分析[J]．中国医师杂志，2016,18(11):1723-1725.

[11] ZHU XZ,ZHAI YF,WANG JJ. Study on the risk factors of the occurrence of hepato renal syndrome for patients with acute on chronic hepatitis B liver failure[J]. J Chin Physician,2014,16(9):1196-1199.(in Chinese)朱喜增，翟玉峰，王江华．慢加急性乙型肝炎肝衰竭患者发生肝肾综合征的影响因素研究[J]．中国医师杂志，2014,16(9):1196-1199.

[12] YE YN,ZHANG ZJ,HE G,et al. Analysis of high-risk factors for hepatorenal syndrome in patients with hepatitis B-related acute-on-chronic liver failure[J]. Hainan Med J,2019,30(24):3145-3148.(in Chinese)叶一农，张志侨，何纲，等．乙型肝炎相关慢加急性肝衰竭患者发生肝肾综合征的高危因素分析[J]．海南医学，2019,30(24):3145-3148.

[13] ARROYO V,GINES P,GERBES AL,et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club[J]. Hepatology,1996,23(1):164-176.

[14] SALERNO F,GERBES A,GINES P,et al. Diagnosis,prevention and treatment of hepatorenal syndrome in cirrhosis[J].Gut,2007,56(9):1310-1318.

[15] ANGELI P,GINES P,WONG F,et al. Diagnosis and management of acute kidney injury in patients with cirrhosis:Revised consensus recommendations of the International Club of Ascites[J]. J Hepatol,2015,62(4):968-974.

[16] Chinese Society of Hepatology,Chinese Medical Association.Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol,2017,33(10):1847-1863.(in Chinese)中华医学会肝病分会．肝硬化腹水及相关并发症的诊疗指南[J]．临床肝胆病杂志，2017,33(10):1874-1863.

[17] BELCHER JM,EDELSTEIN CL,PARIKH CR. Clinical applications of biomarkers for acute kidney injury[J]. Am J Kidney Dis,2011,57(6):930-940.

[18] BELCHER JM,SANYAL AJ,PEIXOTO AJ,et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury[J]. Hepatology,2014,60(2):622-632.

[19] HUELIN P,SOLAE,ELIA C,et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis:A prospective study[J]. Hepatology,2019,70(1):319-333.

[20] AMIN AA,ALABSAWY EI,JALAN R,et al. Epidemiology,pathophysiology,and management of hepatorenal syndrome[J]. Semin Nephrol,2019,39(1):17-30.

[21] European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol,2018,69(2):406-460.

[22] CHAWLA LS,BELLOMO R,BIHORAC A,et al. Acute kidney disease and renal recovery:Consensus report of the Acute Disease Quality Initiative(ADQI)16 Workgroup[J]. Nat Rev Nephrol,2017,13(4):241-257.

[23] HUAN HD,CHENG CW. Latest advances in the definition,typing,and pathophysiology of hepatorenal syndrome[J].Chin Hepatol,2020,25(1):7-9.(in Chinese)宦红娣，陈成伟．肝肾综合征定义、分型及病理生理新进展[J]．肝脏，2020,25(1):7-9.

[24] ANGELI P,GARCIA-TSAO G,NADIM MK,et al. News in pathophysiology,definition and classification of hepatorenal syndrome:A step beyond the International Club of Ascites(ICA)consensus document[J]. J Hepatol,2019,71(4):811-822.

施引文献

资源附件(0)

访问统计